compounded vs non compounded glp 1 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Should GLP-1 Drugs Be Over

Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9)

It contains semaglutide, the same active ingredient found in Ozempic and Wegovy, but in tablet form

Is 0.5 mg equal to 20 units

As demonstrated in healthy human volunteers, GLP-1 infusion acutely increases blood flow in the subcutaneous abdominal adipose tissue and skeletal muscle without alterations in splanchnic blood flow [650]

improved glycaemic control and reduced inflammation could plausibly reduce susceptible states for candidiasis/vaginitis

Ready to Begin Your Journey